Recent large outbreaks of Zika virus infection worldwide have revealed an 60 association between the viral infection and increased cases of specific 61 neurological problems including Congenital Zika Syndrome (including 62 microcephaly) and adult Guillain-Barré Syndrome. However, the determinants 63 of the increased neurovirulence of Zika virus remain uncertain. One hypothesis 64 is that some unique changes across the Zika viral genome have led to the 65 occurrence of these neurological diseases. To test this hypothesis, we 66 continuously propagated a clinical isolate of contemporary Zika virus (SW01) in 67 neonatal mice brain for 11 times to obtain an mouse central nervous system 68 (CNS) adapted Zika virus (MA-SW01) that showed significantly increased 69 neurovirulence in vivo. We then discovered that a single G to A nucleotide 70 substitution at the 1069 site of Zika virus open reading frame leading to a D 71 (aspartic acid) to N (asparagine) in viral Envelope protein is responsible for the 72 increased neurovirulence. These findings improve our understanding of the 73 neurological pathogenesis of Zika virus and provide clues for the development 74 of antiviral strategy. 75 76 77 78 79 80 81 82 83 84 85 86 87 5 / 32
). Toghther with previous results (Fig.2C) , these data indicate that the 199 virulence of MA-SW01 is age-dependent, but not related to the route of infection. 200 To examine whether the increased virulence of the mouse adapted MA-SW01 201 virus is limited to only one specific mouse strain, we next injected s.c. to DP2 202 C57/BL6 mice with either SW01 or MA-SW01 virus, or sterile PBS as control, 203 and then monitored them for 15 days. Results showed that MA-SW01 infected 204 C57/BL6 mice exhibited 100% mortality at 6-7 days post infection, whereas only 205 44.4% of SW01 infected mice died at 15 days post infection (Fig.S2) . Thus, the 206 increased virulence of mouse adapted MA-SW01 virus is not restricted to one 207 specific mouse strain. Increase virulence of MA-SW01 is associated with greater viral replication 210 in multiple organs including brain 211 Previous studies have shown that a low-dose of Zika virus infection (210 3 212 PFU) in C57/BL6 neonates led to a limited but detectable level of infection in 213 mouse brain, and a lower mortality rate than infection of immune deficient A6 214 mice (IFNα/βR -/-, C57/BL6 background) (31). In comparison, a high-dose of 215 Zika virus infection (10 6 TCID50) in P1 neonatal C57/BL6 mice caused systemic 216 infection and 100% death (32). To examine whether the MA-SW01 virus has 217 adapted to replicate more efficiently in mice to cause systemic infection, and 218 consequently increased virulence, DP2 Balb/c mice were infected s.c. with 100 219 PFU of SW01 virus or MA-SW01 virus, and then the viral loads in tissues 220 including brain, eyes, blood, spleen, and kidney were quantified by real time-221 qPCR at 3 and 6 days post infection. Results showed that higher level of Zika 222 virus RNA was detected in the brain of MA-SW01 infected mice at 3 days post 223 infection, and higher viral loads in multiple tissues (brain, eye, blood and spleen) 224 were observed in MA-SW01 infected mice than SW01 infected mice at 6 days 225 post infection (Fig.3A) . Specifically, the average viral RNA level in the brain of 226 MA-SW01 infected mice was about 15-fold and 488-fold higher than that of 227 SW01 infected mice at 3 and 6 days post infection, respectively; in eyes, the 228 average viral RNA level of MA-SW01 infected mice was 22-fold higher than that 229 of SW01 infected mice at 6 days post infection; in spleen, the average viral RNA 230 level of MA-SW01 infected mice exhibited approximately 5-fold increase 231 compared to SW01 infected mice at 6 days after infection; in blood, the average 232 viral RNA level of MA-SW01 infected mice was 54-fold higher than mice 233 infected by SW01 virus at 6 days post infection( Fig.3A) .
234
It is interesting to note that the average viral copy number in the brain of MA-235 SW01 infected mice was dramatically higher (about 488-fold) than that of SW01 236 infected mice at day 6 post infection (Fig.3A ). More viruses in the brain may be 237 explained by two possibilities, one is that MA-SW01 virus replicates more 238 efficiently than SW01 in the central nerve system (CNS); another is that MA-239 SW01 virus has increased neuro-invasion efficiency. To investigate these two 240 possibilities, DP2 Balb/c mice were infected with 100 PFU SW01 virus or MA-241 SW01 virus by intracranial (i.c.) inoculation and viral RNA in the brains were 242 quantified by real-time qPCR. Results showed that viral RNA of MA-SW01 243 group was not significantly different from that of SW01 group at 3 days post 244 infection ( Fig.3B ), but 13.8 fold higher than that of SW01 group at 6 days post 245 infection ( Fig.3C ), suggesting more efficient replication of MA-SW01 in the 246 brain. Given that viral RNA level in the brain of MA-SW01 group was about 15 247 fold higher than that of SW01 group at day 3, even with s.c. inoculation (Fig.3A) , 248 we deduced that the more virulent MA-SW01 virus has great penetration to 249 brain. To more directly visualize viral infection in the brain, immunofluorescence 250 staining of virus E protein in brain tissue sections was performed. Dramatically 251 stronger fluorescent intensity indicating Zika virus E protein was detected in 252 MA-SW01 infected mouse brains at 6 days post infection, compared to that 253 inSW01 infected mice ( Fig.3D ). More detailed brain staining analyses showed 254 that cortex and hippocampus regions are major sites for MA-SW01 infection 255 ( Fig.S3A, S3B, and S3C) , albeit the specific target cells in these tissues are 256 currently unclear. Collectively, the above data indicate that MA-SW01 virus also 257 has increased tropism to neuronal tissues.
259
The MA-SW01 virus has four high frequency nonsynonymous mutations 260 To exploit whether the increased virulence of mouse adapted MA-SW01 virus 261 is the result of unique genetic characteristics or quasispecies properties, we 262 compared the MA-SW01 virus with its parental virus SW01 at the phenotypic 263 and genetic levels. Biological clones derived from MA-SW01 virus (MA-1, MA-264 2, MA-3, MA-4, MA-5, MA-6, MA-7, MA-8, MA-9 and MA-10) were found to be 265 more virulent than clones from SW01 (SW-1, SW-2, SW-3, and SW-4) ( Fig.S4) , 266 indicating the increased virulence of MA-SW01 is not a reflection of viral 267 quasispecies but may be related to specific genetic characteristics. To uncover However, when Zika virus was inoculated intracranially in neonatal mice, the 284 deletion of N154 glycosylation had no impact on virus virulence (40).
285
Collectively, these published data suggest that the N154D mutation may not be 286 linked to the augmented infectivity and increased neurovirulce we have 287 observed for the mouse adapted MA-SW01 virus. Hence, we focused on the 288 other 3 amino acid mutations (D67N, M68I on E protein, and A117T on NS2A Mutations on E protein are required for increased virulence 292 Based on a widely used Zika virus infectious clone pFLZIKV (41), three mutant 293 viruses (CM1, CM2 and CM3) were constructed: CM1 includes D67N and M68I 294 mutations on E protein; CM2 includes the A117T mutation on NS2A protein; 295 CM3 contains all three substitutions on E and NS2A proteins ( Fig.5A ). In BHK-296 21 cells, 1-3 days after transfection with in vitro transcripted RNA from these 297 viral constructs, virus E protein expression was examined with a monoclonal 298 antibody. Results showed that all three molecularly cloned mutate viruses were 299 rescued and replicated efficiently ( Fig.5B ). These molecularly cloned mutant 300 viruses (CM1, CM2, and CM3 virus) were then used to infect DP2 Balb/c mice 301 i.c. at 10 PFU/mouse, using the parental molecularly cloned CAM-WT virus as 302 a control, and then monitored for 25 days. Results showed that CM1 and CM3, 303 but not CM2, were more virulent than parental virus CAM-WT in neonatal mice 304 ( Fig.5C ). Since both CM1 and CM3 contain 2 mutations on E protein (D67N, 305 M68I), and CM2 only contains the single NS2A mutation, the above results 306 suggest that the E protein mutations were determinants of increased virulence 307 of MA-SW01, and the NS2A mutation was not. Therefore, CM1 virus containing 308 two E protein mutations was chosen for further investigation. 309 We first examined whether the route of infection alters viral virulence. DP2
310
Balb/c mice were infected s.c. with 100 PFU of control CAM-WT or test CM1 311 virus, and then monitored for up to 25 days. Results showed that CM1 infection 312 led to higher motality than that of CAM-WT ( Fig.5D ). Although a difference was 313 not observed earlier at 3 days post infection ( Fig.5E ), body weight recorded at 314 11 days post infection showed that CM1 infected mice were significantly lighter 315 than those infected by CAM-WT ( Fig.5F ). Notably, disease progression 316 appeared to be reversible in the control CAM-WT group, but not so in the CM1 317 group which had 100% mortality at 17 days post infection ( Fig.5G, 5H) . These 318 data demonstrated that the severe outcome as a result of CM1 infection is not 319 constrained by inoculation routes.
320
Since virulence of the mouse adapted MA-SW01 virus was not restricted to a 321 single mouse strain, we sought to confirm that the molecularly cloned CM1 viurs 322 follows the same principle. DP2 C57/BL6 mice were inoculated s.c. with 100 323 PFU of parental CAM-WT or test CM1, or negative control PBS, and then 324 monitored for 25 days. All mice (100%) infected by CM1 virus died at 11-13 325 days post infection, whereas only 20% of those infected by CAM-WT 326 succumbed at 25 days post infection (Fig.S5 ). These data demonstrated that 327 the virulent phenotype of CM1 is not mouse strain specific. To determine which one of the two amino acids is more critical for a major 332 change in viral phenotype, we first analyzed single nucleotide variants in E 333 protein sequence from serially passaged P1 (MA-P1) to P11 (MA-P11) viruses.
334
Results revealed that there were progressive accumulations of D67N (from 22.7% 335 to 99.4%), and M68I (from 3.0 % to 91.7%) mutations during the in vivo serial 336 passage of parental SW01 virus. The baseline frequencies of these two 337 mutations in the parental virus (P0, or SW01) were lower than 1%. Of note, the 338 D67N maintained high mutation frequency (>90%) from P5 to P11 during in vivo 339 passage ( Fig.6A ). Consistent with the notion that this mutation may be 340 functionally significant, DP2 C57/BL6 mice infected with 100 PFU of MA-P5,
341
MA-P8 or MA-P10 showed 100% mortality at 10 days post infection, whereas 342 the parental virus SW01 infected mice had only 16.7% mortality at 15 days post 343 infection ( Fig.6B) . Given that the D67N mutation rapidly increased to 92.4% in 344 P5 virus (Fig.6B ), and all single biological clones of the mouse adapted MA-345 SW01 virus contain the D67N mutation (Table.S1), it is reasonalb to deduce 346 that D67N mutation alone is responsible for the increased viral virulence. To 347 test this idea, a molecular clone contains the single D67N mutation was 348 constructed based on the CAM-WT backbone (pFLZIKV), and herein named 349 CM1-A virus (Fig.6C) , which was rescued successfully as showed by showed that CM1-A was similar to CM1 in causing 100% mortality of infected 355 mice at 12-13 days post infection (Fig.6E ). These data demonstrated that a 356 single D67N mutation is sufficient to account for the increased virulence of CM1. RNA between CAM-WT and CM1 groups; at 11 days post infection, however, 365 viral RNA of CM1 group was significantly higher than that of CAM-WT group in 366 brains, eyes and blood, but not in spleens and kidneys (Fig.7A ), confirming the 367 combination of these E protein mutations affect tissue tropism.
368
The fact that more viral RNA was detected in brain and eyes, that are rich in 369 nerve cells susceptible to Zika virus infection, implies that CM1 virus has growth 370 advantage over CAM-WT in these cells. To directly test this notion, DP2 Balb/c 371 mice were infected i.c. with CAM-WT or CM1, and then monitored for virus 372 burden by real-time qPCR. Results showed that brain viral loads of CM1 group 373 was higher than that of CAM-WT group at 11 days post infection, but not 3 days 374 post infection ( Fig.7C, 7D ), suggesting that CM1 has growth advantage over 375 CAM-WT in brain.
376
To further dissect wthether single D67N mutation in E protein plays the essential 377 role of altering viral virulence and tissue tropism, we next used CM1-A virus 378 (containing only D67N ) to perform viral infection experiments. Results showed 379 that irrespective of throught s.c. infection (Fig.7B ), or i.c. infection (Fig.7C, 7D) , 380 viral load in brains of CM1-A group were always higher than that of CAM-WT 381 group at 11 days post infection, but not at 3 days post infection. Collectively, 382 these data indicated that D67N mutation promotes virus virulence partially 383 through enhancing virus replication in CNS. (Fig.6A, 6B) , it is reasonable to deduce 395 that D67N substitution provides more viral fitness in CNS, and thus enables 396 MA-SW01 to outgrow other viral variants within the SW01 quasispecies. The specific mechanisms that explain why a single D67N mutation on E protein 428 can dramatically change Zika virus infectivity is currently unknown. One reason 429 may be its potential link to glycosylation. In all four DENV serotypes, there are 430 two highly conserved N-linked glycosylation sites on E protein, N67 and N153, 431 that play critical role for viral entry (42). However, similar to West Nile virus 432 (WNV) and Japanes encephalitis virus (JEV), Zika virus has only one N154 433 glycosylation site on E protein (40, 43) . Indeed, glycosylation on N153 or N154 434 of E protein helps WNV or JEV to invade CNS in mammals (38, 39, 44, 45) . (carboxymethylcellulose), then incubated at 37°C, 5%CO2 for 96 hours. Four 518 days later, the overlay was removed and cells were fixed with 4% PFA for 30min.
519
The viral plaque was visualized and calculated after being stained by 0.25% 520 crystal violet. 
